These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 10172689)

  • 1. Toward cost-effective care for persons with dual diagnoses.
    Jerrell JM
    J Ment Health Adm; 1996; 23(3):329-37. PubMed ID: 10172689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating changes in symptoms and functioning of dually diagnosed clients in specialized treatment.
    Jerrell JM; Ridgely MS
    Psychiatr Serv; 1995 Mar; 46(3):233-8. PubMed ID: 7796208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual diagnosis care for severe and persistent disorders. A comparison of three methods.
    Jerrell JM; Ridgely MS
    Behav Healthc Tomorrow; 1997 Jun; 6(3):26-33. PubMed ID: 10173086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effectiveness of three approaches to serving people with severe mental illness and substance abuse disorders.
    Jerrell JM; Ridgely MS
    J Nerv Ment Dis; 1995 Sep; 183(9):566-76. PubMed ID: 7561818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Private sector coverage of people with dual diagnoses.
    Garnick DW; Hendricks AM; Drainoni M; Horgan CM; Comstock C
    J Ment Health Adm; 1996; 23(3):317-28. PubMed ID: 10172688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of robustness of program implementation on outcomes of clients in dual diagnosis programs.
    Jerrell JM; Ridgely MS
    Psychiatr Serv; 1999 Jan; 50(1):109-12. PubMed ID: 9890592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender differences in the assessment of specialized treatments for substance abuse among people with severe mental illness.
    Jerrell JM; Ridgely MS
    J Psychoactive Drugs; 1995; 27(4):347-55. PubMed ID: 8788691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality as the driving force for cost-effective psychiatric managed care.
    Roberts B
    J Healthc Qual; 1996; 18(1):4-8; quiz 8, 44. PubMed ID: 10172546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dual diagnosis demonstration project: treatment outcomes and cost analysis.
    Judd PH; Thomas N; Schwartz T; Outcalt A; Hough R
    J Psychoactive Drugs; 2003 May; 35 Suppl 1():181-92. PubMed ID: 12825761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of assertive community treatment versus standard case management for persons with co-occurring severe mental illness and substance use disorders.
    Clark RE; Teague GB; Ricketts SK; Bush PW; Xie H; McGuire TG; Drake RE; McHugo GJ; Keller AM; Zubkoff M
    Health Serv Res; 1998 Dec; 33(5 Pt 1):1285-308. PubMed ID: 9865221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
    Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
    J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persons with dual diagnoses of substance abuse and major mental illness: their excess costs of psychiatric care.
    Dickey B; Azeni H
    Am J Public Health; 1996 Jul; 86(7):973-7. PubMed ID: 8669521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The costs of behavioral health care coverage.
    Sterman P
    Empl Benefits J; 1997 Mar; 22(1):2-10. PubMed ID: 10172938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and growth of managed behavioral health care firms.
    Kihlstrom LC
    Health Aff (Millwood); 1997; 16(4):127-30. PubMed ID: 9248156
    [No Abstract]   [Full Text] [Related]  

  • 15. Cost-effectiveness of mental health services for persons with a dual diagnosis: a literature review and the CCMHCP. The Cost-Effectiveness of Community Mental Health Care for Single and Dually Diagnosed Project.
    Johnson J
    J Subst Abuse Treat; 2000 Mar; 18(2):119-27. PubMed ID: 10716095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment for dual diagnosis patients in the psychiatric and substance abuse systems.
    Timko C; Dixon K; Moos RH
    Ment Health Serv Res; 2005 Dec; 7(4):229-42. PubMed ID: 16320106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes and costs of matching the intensity of dual-diagnosis treatment to patients' symptom severity.
    Chen S; Barnett PG; Sempel JM; Timko C
    J Subst Abuse Treat; 2006 Jul; 31(1):95-105. PubMed ID: 16814015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of managing disability benefits among patients with substance dependence and severe mental illness.
    Ries RK; Dyck DG; Short R; Srebnik D; Fisher A; Comtois KA
    Psychiatr Serv; 2004 Apr; 55(4):445-7. PubMed ID: 15067161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with high levels of spending for younger dually eligible beneficiaries with mental disorders.
    Frank RG; Epstein AM
    Health Aff (Millwood); 2014 Jun; 33(6):1006-13. PubMed ID: 24889950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. More is less: increasing access as a strategy for managing health care costs.
    Fuller MG
    Psychiatr Serv; 1995 Oct; 46(10):1015-7. PubMed ID: 8829781
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.